Your browser doesn't support javascript.
loading
Effect of Astragalus polysaccharides on expression of TNF-α, IL-1ß and NFATc4 in a rat model of experimental colitis.
Yang, Min; Lin, Huan-Bing; Gong, Sitang; Chen, Pei-Yu; Geng, Lan-Lan; Zeng, Yong-Mei; Li, Ding-You.
Afiliação
  • Yang M; Department of Gastroenterology, Guangzhou Women and Children's Medical Center of Guangzhou Medical College, Guangzhou, China.
  • Lin HB; Guangdong Food and Drug Administration Center for Evaluation and Certification, Guangzhou, China.
  • Gong S; Department of Gastroenterology, Guangzhou Women and Children's Medical Center of Guangzhou Medical College, Guangzhou, China.
  • Chen PY; Department of Gastroenterology, Guangzhou Women and Children's Medical Center of Guangzhou Medical College, Guangzhou, China.
  • Geng LL; Department of Gastroenterology, Guangzhou Women and Children's Medical Center of Guangzhou Medical College, Guangzhou, China.
  • Zeng YM; Department of Gastroenterology, Guangzhou Women and Children's Medical Center of Guangzhou Medical College, Guangzhou, China.
  • Li DY; Division of Gastroenterology, Children's Mercy Hospital, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA. Electronic address: dyli@cmh.edu.
Cytokine ; 70(2): 81-6, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25132256
ABSTRACT

AIM:

Astragalus membranaceus is a Chinese medicinal herb and has been shown to improve hapten-induced experimental colitis. One of its major components is polysaccharides. We investigated the effect of Astragalus polysaccharides (APS) on expression of TNF-α, IL-1ß and NFATc4 in a rat model of experimental colitis.

METHODS:

The experimental colitis model was induced by TNBS. Forty five rats were divided into five groups (n=9) Normal control group, receiving ethanol vehicle with no TNBS during induction and IP saline injection during treatment; TNBS colitis model group (TNBS+IP saline), receiving only IP saline vehicle treatment; APS low dose group (TNBS+L-APS), receiving APS 100mg/kg; APS high dose group (TNBS+H-APS), receiving APS 200mg/kg; and positive control group (TNBS+Dexm), receiving dexamethasone 0.3mg/kg. The clinical features, macroscopic and microscopic scores were assessed. The expressions of TNF-α, IL-1ß and NFATc4 were measured by real-time PCR and ELISA assays.

RESULTS:

Compared to normal control rats, TNBS+IP saline had significant weight loss, increased macroscopic and microscopic scores, higher disease activity index (DAI) up-regulation of TNF-α, IL-1ß and NFATc4 mRNA expression and up-regulation of TNF-α and IL-1ß protein expression. Compared to TNBS+IP saline, treatment with APS or dexamethasone significantly reduced DAI, partially but significantly prevented TNBS colitis-induced weight loss and improved both macroscopic and microscopic scores; high dose APS or dexamethasone significantly down-regulated TNF-α and IL-1ß expressions (both mRNA and protein) and up-regulated NFATc4 mRNA and protein expression. The effect of high dose APS and dexamethasone is comparable.

CONCLUSIONS:

APS significantly improved experimental TNBS-induced colitis in rats through regulation of TNF-α, IL-1ß and NFATc4 expression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polissacarídeos / Fator de Necrose Tumoral alfa / Colite / Astragalus propinquus / Fatores de Transcrição NFATC / Interleucina-1beta / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polissacarídeos / Fator de Necrose Tumoral alfa / Colite / Astragalus propinquus / Fatores de Transcrição NFATC / Interleucina-1beta / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article